Open AccessSurveillance assessment for veterinary biocidal products in Korea: A laboratory investigation
Author(s) -
Kang JeongWoo,
Hossain Md Akil,
Park Haechul,
Song JaeYoung,
Kim YongSang,
Jeong Mi young,
Chung GabSoo,
Lee HyeSook,
Yoon HyeongJun,
Park Sungwon,
Lee Kwangjick
Publication year - 2021
Publication title -
veterinary medicine and science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.485
H-Index - 11
ISSN - 2053-1095
DOI - 10.1002/vms3.385
Subject(s) - amitraz , dichlorvos , coumaphos , acaricide , toxicology , veterinary drug , pesticide , abamectin , chlorpyrifos , acetamiprid , methomyl , pyrimethanil , active ingredient , veterinary drugs , chemistry , veterinary medicine , biology , imidacloprid , chromatography , medicine , bioinformatics , agronomy
Veterinary biocides used in animal husbandry have the potential to cause human health concerns. Biocidal products for veterinary use, which contain pesticides approved in Korea, comprise 49 active ingredients within 234 products. Within 17 of these products there are 3 ingredients which are highly hazardous pesticides: coumaphos, dichlorvos and methomyl. In this study, the content of the active ingredients of 160 products sold domestically was investigated. Samples were collected for 119 biocidal products for veterinary use. These were analysed by high‐performance liquid chromatography (HPLC) and gas chromatography (GC). Seventeen products were noncompliant (insufficient or excess quantity of active ingredients). The ingredients that were below the stated concentrations were amitraz, chlorpyrifos‐methyl, cypermethrin, cyromazine, dichlorvos, fipronil, muscamone and trichlorfon. The ingredients that exceeded the stated concentrations were abamectin, fluvalinate and pyriproxyfen. The noncompliance rate in biocidal products for veterinary use was 9.19%. The results of this study show that three highly hazardous pesticides (coumaphos, dichlorvos and methomyl) and 10 active ingredients (abamectin, amitraz, chlorpyrifos‐methyl, cypermethrin, cyromazine, fipronil, fluvalinate, muscamone, pyriproxyfen and trichlorfon) deviated from the stated concentrations. Thus, management plans should be established to ensure compliant veterinary drugs by post‐distribution quality control, such as planning for regular inspection.